Association of a Self-Paid Medically Supervised Weight Management Program with Reversal of Obesity-Associated Impaired Fasting Glucose.
impaired fasting glucose
obesity
personalized weight management
prediabetes
weight loss
Journal
Clinics and practice
ISSN: 2039-7275
Titre abrégé: Clin Pract
Pays: Switzerland
ID NLM: 101563282
Informations de publication
Date de publication:
15 Jun 2021
15 Jun 2021
Historique:
received:
07
05
2021
revised:
08
06
2021
accepted:
09
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
The progression of prediabetes to T2DM can be delayed through diet modification and weight management. However, the intensive lifestyle program is often not covered by medical insurance. This retrospective analysis evaluates the association of a patient self-paid weight management program on an improvement of blood sugar in overweight and obese patients with impaired fasting glucose (IFG). The medical records of 4634 patients who participated in the self-pay UCLA Weight Management Program were reviewed and 2572 patients met the criteria for this retrospective analysis to examine whether this program was associated with the reversal of IFG over 3 months among 1396 patients with normal fasting glucose (NFG) and 1176 with IFG. The patients with IFG lost comparable amounts of weight (10.5 ± 1.3 kg) at three months, as did the subjects with NFG (10.1 ± 1.3 kg). Fasting blood glucose in the IFG group decreased from 108.49 ± 6.4 to 101.8 ± 9.41 mg/dL ( Our medically supervised self-pay multidisciplinary weight management program was associated with reduced fasting blood glucose levels in patients with IFG over three months with comparable weight loss to patients with NFG.
Identifiants
pubmed: 34203799
pii: clinpract11020053
doi: 10.3390/clinpract11020053
pmc: PMC8293166
doi:
Types de publication
Journal Article
Langues
eng
Pagination
386-394Références
Nat Rev Endocrinol. 2020 Jul;16(7):395-400
pubmed: 32060416
JAMA. 2003 Jan 1;289(1):76-9
pubmed: 12503980
JBI Libr Syst Rev. 2008;6(4 Suppl):1-12
pubmed: 27819934
Endocrine. 2015 Mar;48(2):371-93
pubmed: 25294012
Nutr Diabetes. 2014 Feb 10;4:e105
pubmed: 24513578
Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461
pubmed: 31036503
Diabetes Care. 2011 Oct;34(10):2152-7
pubmed: 21836103
Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31
pubmed: 19635784
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
J Am Heart Assoc. 2019 Feb 5;8(3):e010628
pubmed: 30686107
BMC Endocr Disord. 2018 Dec 4;18(1):91
pubmed: 30514382
Diabetes Res Clin Pract. 2007 Dec;78(3):305-12
pubmed: 17601626
J Am Coll Cardiol. 2010 Mar 30;55(13):1310-7
pubmed: 20338491
Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93
pubmed: 18493227
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
Nurs Clin North Am. 2017 Dec;52(4):665-677
pubmed: 29080583
Ann Intern Med. 2015 Apr 7;162(7):501-12
pubmed: 25844997
Diabetes Care. 2011 Jun;34(6):1249-57
pubmed: 21617109
BMJ Open Diabetes Res Care. 2019 Jul 29;7(1):e000659
pubmed: 31413841
J Clin Endocrinol Metab. 2019 Jul 31;:
pubmed: 31365087
High Blood Press Cardiovasc Prev. 2015 Dec;22(4):389-94
pubmed: 25986079
Sci Rep. 2019 Aug 15;9(1):11927
pubmed: 31417128
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
Obes Rev. 2016 Aug;17(8):758-69
pubmed: 27230990